Optimal choice of prophylactic anticoagulant therapy for nonvalvular atrial fibrillation in the context of COVID-19 pandemic
Already at the very beginning of COVID-19 pandemic, it became known about the key clinical and pathogenetic significance of immunopathological reactions and disorders of hemostasis. Specific coagulopathy, microvascular thromboinflammatory organ damage, macrothrombosis and thromboembolism in the acut...
Saved in:
| Main Authors: | A. S. Polyakov, V. V. Tyrenko, E. V. Kryukov, Ya. A. Noskov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2021-09-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4607 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01) -
Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01) -
Maximum time between cardiac cycles in atrial fibrillation for assessing the risk of arterial thromboembolism
by: O. A. Germanova, et al.
Published: (2022-08-01) -
MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01) -
Patients with atrial fibrillation and a low risk of thromboembolic events: prescription rate of anticoagulant therapy according to a retrospective analysis
by: M. A. Druzhilov, et al.
Published: (2023-09-01)